These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Role of frontline autologous stem cell transplantation in young, high-risk diffuse large B-cell lymphoma patients. Yoon JH; Kim JW; Jeon YW; Lee SE; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Min WS; Park CW; Cho SG Korean J Intern Med; 2015 May; 30(3):362-71. PubMed ID: 25995667 [TBL] [Abstract][Full Text] [Related]
7. Autologous hematopoietic stem cell transplantation as first-line consolidation therapy can improve the prognosis of diffuse large B-cell lymphoma with high expression of MYC protein. Hu K; Gao JJ; Li QH; Tian L; Wan W; Zhao W; Wang JJ; Fu L Kaohsiung J Med Sci; 2019 Jul; 35(7):425-431. PubMed ID: 31050117 [TBL] [Abstract][Full Text] [Related]
8. High-risk diffuse large B-cell lymphoma: can we do better than rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone? George A; Tam CS; Seymour JF Leuk Lymphoma; 2013 Dec; 54(12):2575-6. PubMed ID: 23597141 [No Abstract] [Full Text] [Related]
10. Primary ovarian lymphoma--a rare entity. Afshan A; Sadaf N J Pak Med Assoc; 2013 Apr; 63(4):519-20. PubMed ID: 23905454 [TBL] [Abstract][Full Text] [Related]
11. Managing early failures with R-CHOP in patients with diffuse large B-cell lymphoma. Camus V; Tilly H Expert Rev Hematol; 2017 Dec; 10(12):1047-1055. PubMed ID: 27791447 [TBL] [Abstract][Full Text] [Related]
12. Diffuse large B cell lymphoma cell of origin by digital expression profiling in the REAL07 Phase 1-2 study. Cascione L; Rinaldi A; Chiappella A; Kwee I; Ciccone G; Altenbuchinger M; Kohler C; Vitolo U; Inghirami G; Bertoni F Br J Haematol; 2018 Aug; 182(3):453-456. PubMed ID: 28737236 [No Abstract] [Full Text] [Related]
13. Outcomes with R-CEOP for R-CHOP-ineligible patients with diffuse large B-cell lymphoma are highly dependent on cell of origin defined by Hans criteria. Rashidi A; Oak E; Carson KR; Wagner-Johnston ND; Kreisel F; Bartlett NL Leuk Lymphoma; 2016 May; 57(5):1191-3. PubMed ID: 26397936 [No Abstract] [Full Text] [Related]
14. [Initial treatment of diffuse large B-cell lymphoma]. Kinoshita T Nihon Rinsho; 2012 Apr; 70 Suppl 2():503-8. PubMed ID: 23134006 [No Abstract] [Full Text] [Related]
15. The impacts of initial and relative dose intensity of R-CHOP on outcomes of elderly patients with diffuse large B-cell lymphoma. Kanemasa Y; Shimoyama T; Sasaki Y; Tamura M; Sawada T; Omuro Y; Hishima T; Maeda Y Leuk Lymphoma; 2017 Mar; 58(3):736-739. PubMed ID: 27686739 [No Abstract] [Full Text] [Related]
16. [Diffuse large B-cell lymphoma following nodular lymphocyte predominant Hodgkin's lymphoma: report of a case]. Chen DB; Wang Y; Shen DH Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):635-6. PubMed ID: 21092597 [No Abstract] [Full Text] [Related]